Latest Corporate News
Cellipont Bioservices and Mongoose Bio Sign Agreement to Advance MGB-001, its Lead TCR-T therapy, towards the Clinic for Multiple Cancers
The Woodlands and Houston, Texas, October 8, 2024/ Cision / – Cellipon...
Cellipont Bioservices Announces Darren Head As Chief Executive Officer & Minority Growth Equity Investment From HealthQuest Capital
The Woodlands, TX, October 7, 2024 - Cellipont Bioservices, a leading...
Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform
Cellipont Bioservices, a leading cell therapy Contract Development and...
Press Inquiry? Send us a message